imc-p115c
·Code: PRAME-HLE-A02
imc-p115c: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Immunocore Holdings plc (IMCR) | Phase 1 |
Clinical Trials (1)
A Phase 1 First-in-Human Study of the Safety and Efficacy of IMC-P115C as a Single Agent and in Combination With Standard of Care Agents in HLA-A*02:01 Positive Participants With Advanced PRAME Positive Cancers
Frequently asked questions
Who is developing imc-p115c?
imc-p115c is being developed by Immunocore Holdings plc.
How many clinical trials involve imc-p115c?
BioSniper tracks 1 clinical trial involving imc-p115c.
Get deeper analysis on imc-p115c
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis